Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis

A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and so...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Edita Fino, Paolo Maria Russo, Vera Tengattini, Federico Bardazzi, Annalisa Patrizi, Monica Martoni
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/947995bb6b1a403cb55e409665d238e4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:947995bb6b1a403cb55e409665d238e4
record_format dspace
spelling oai:doaj.org-article:947995bb6b1a403cb55e409665d238e42021-11-25T18:08:16ZIndividual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis10.3390/jpm111112362075-4426https://doaj.org/article/947995bb6b1a403cb55e409665d238e42021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1236https://doaj.org/toc/2075-4426A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and social anxiety in modulating quality of life in psoriatic patients. A total of 130 patients affected by psoriasis were consecutively enrolled in the study as they approached the Dermatology Unit of Sant’Orsola-Malpighi Hospital of Bologna. Clinical information gathered included illness severity, assessed with the Psoriasis Area and Severity Index (PASI) and the Body Surface Area (BSA); illness onset; familiarity; and prescribed treatment. The patient-reported outcome measures were the Dermatology Life Quality Index (DLQI), measuring the patient’s quality of life; the Psoriasis Skin Appearance Bothersomeness scale (PSAB), measuring patient’s perception of illness severity; the Difficulties in Emotion Regulation Scale (DERS), assessing emotion dysregulation traits; and the Social Interaction Anxiety Scale (SIAS), measuring anxiety about social interactions. Patients with moderate-to-severe psoriasis reported significantly lower quality of life compared to mildly affected patients. In addition, of the patients affected by mild psoriasis, those characterized by emotion dysregulation and social anxiety traits showed significantly lower levels of quality of life. Our findings suggest that individual differences in emotion dysregulation and social anxiety contribute to health-related quality of life in addition to illness severity. Therapeutic approaches that combine dermatological care with psychological support, especially focused on emotional regulation skills, may be useful to improve clinical outcomes in patients with psoriasis.Edita FinoPaolo Maria RussoVera TengattiniFederico BardazziAnnalisa PatriziMonica MartoniMDPI AGarticleemotion dysregulationhealth-related quality of lifeindividual differencessocial anxietypsoriasisMedicineRENJournal of Personalized Medicine, Vol 11, Iss 1236, p 1236 (2021)
institution DOAJ
collection DOAJ
language EN
topic emotion dysregulation
health-related quality of life
individual differences
social anxiety
psoriasis
Medicine
R
spellingShingle emotion dysregulation
health-related quality of life
individual differences
social anxiety
psoriasis
Medicine
R
Edita Fino
Paolo Maria Russo
Vera Tengattini
Federico Bardazzi
Annalisa Patrizi
Monica Martoni
Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
description A deeper understanding of how health-related quality of life relates to the clinical and individual characteristics of patients is essential for the delivery of patient-centered dermatological care. The current study aimed to examine the role of individual differences in emotion dysregulation and social anxiety in modulating quality of life in psoriatic patients. A total of 130 patients affected by psoriasis were consecutively enrolled in the study as they approached the Dermatology Unit of Sant’Orsola-Malpighi Hospital of Bologna. Clinical information gathered included illness severity, assessed with the Psoriasis Area and Severity Index (PASI) and the Body Surface Area (BSA); illness onset; familiarity; and prescribed treatment. The patient-reported outcome measures were the Dermatology Life Quality Index (DLQI), measuring the patient’s quality of life; the Psoriasis Skin Appearance Bothersomeness scale (PSAB), measuring patient’s perception of illness severity; the Difficulties in Emotion Regulation Scale (DERS), assessing emotion dysregulation traits; and the Social Interaction Anxiety Scale (SIAS), measuring anxiety about social interactions. Patients with moderate-to-severe psoriasis reported significantly lower quality of life compared to mildly affected patients. In addition, of the patients affected by mild psoriasis, those characterized by emotion dysregulation and social anxiety traits showed significantly lower levels of quality of life. Our findings suggest that individual differences in emotion dysregulation and social anxiety contribute to health-related quality of life in addition to illness severity. Therapeutic approaches that combine dermatological care with psychological support, especially focused on emotional regulation skills, may be useful to improve clinical outcomes in patients with psoriasis.
format article
author Edita Fino
Paolo Maria Russo
Vera Tengattini
Federico Bardazzi
Annalisa Patrizi
Monica Martoni
author_facet Edita Fino
Paolo Maria Russo
Vera Tengattini
Federico Bardazzi
Annalisa Patrizi
Monica Martoni
author_sort Edita Fino
title Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_short Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_full Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_fullStr Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_full_unstemmed Individual Differences in Emotion Dysregulation and Social Anxiety Discriminate between High vs. Low Quality of Life in Patients with Mild Psoriasis
title_sort individual differences in emotion dysregulation and social anxiety discriminate between high vs. low quality of life in patients with mild psoriasis
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/947995bb6b1a403cb55e409665d238e4
work_keys_str_mv AT editafino individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT paolomariarusso individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT veratengattini individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT federicobardazzi individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT annalisapatrizi individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
AT monicamartoni individualdifferencesinemotiondysregulationandsocialanxietydiscriminatebetweenhighvslowqualityoflifeinpatientswithmildpsoriasis
_version_ 1718411573060435968